A. Jemal, R. Siegel, and E. Ward, Cancer Statistics, 2007, CA: A Cancer Journal for Clinicians, vol.57, issue.1, pp.43-66, 2007.
DOI : 10.3322/canjclin.57.1.43

E. Finlayson and J. Birkmeyer, Effects of hospital volume on life expectancy after selected cancer operations in older adults: a decision analysis, Journal of the American College of Surgeons, vol.196, issue.3, pp.410-417, 2003.
DOI : 10.1016/S1072-7515(02)01753-2

P. Ghaneh, R. Smith, and C. Tudor-smith, Neoadjuvant and adjuvant strategies for pancreatic cancer, European Journal of Surgical Oncology (EJSO), vol.34, issue.3, pp.297-305, 2007.
DOI : 10.1016/j.ejso.2007.07.204

H. Burris, . Iii, M. Moore, and J. Andersen, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial., Journal of Clinical Oncology, vol.15, issue.6, pp.2403-2416, 1997.
DOI : 10.1200/JCO.1997.15.6.2403

E. Giovannetti, V. Mey, and S. Nannizzi, Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer, Molecular Cancer Therapeutics, vol.5, issue.6, pp.1387-95, 2006.
DOI : 10.1158/1535-7163.MCT-06-0004

J. Hecht, R. Bedford, and J. Abbruzzese, A phase I/ II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma, Clin Cancer Res, vol.9, pp.555-61, 2003.

J. Rommelaere and J. Cornelis, Antineoplasic activity of parvoviruses, Journal of Virological Methods, vol.33, issue.3, pp.233-51, 1991.
DOI : 10.1016/0166-0934(91)90024-T

S. Cotmore and P. Tattersall, The Autonomously Replicating Parvoviruses of Vertebrates, Adv Virus Res, vol.33, pp.91-174, 1987.
DOI : 10.1016/S0065-3527(08)60317-6

A. Haag, P. Menten, and J. Van-damme, Highly Efficient Transduction and Expression of Cytokine Genes in Human Tumor Cells by Means of Autonomous Parvovirus Vectors; Generation of Antitumor Responses in Recipient Mice, Human Gene Therapy, vol.11, issue.4, pp.597-609, 2000.
DOI : 10.1089/10430340050015789

S. Russell, A. Brandenburger, and C. Flemming, Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus, J Virol, vol.66, pp.2821-2829, 1992.

S. Olijslagers, A. Dege, and C. Dinsart, Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin, Cancer Gene Therapy, vol.8, issue.12, pp.958-65, 2001.
DOI : 10.1038/sj.cgt.7700392

D. Piazza, M. Mader, C. Geletneky, and K. , Cytosolic Activation of Cathepsins Mediates Parvovirus H-1-Induced Killing of Cisplatin and TRAIL-Resistant Glioma Cells, Journal of Virology, vol.81, issue.8, pp.4186-98, 2007.
DOI : 10.1128/JVI.02601-06

S. Evrard, P. Keller, and A. Hajri, Experimental pancreatic cancer in the rat treated by photodynamic therapy, British Journal of Surgery, vol.4, issue.8, pp.1185-1194, 1994.
DOI : 10.1002/bjs.1800810835

C. Wrzesinski, L. Tesfay, and N. Salome¤, Chimeric and Pseudotyped Parvoviruses Minimize the Contamination of Recombinant Stocks with Replication-Competent Viruses and Identify a DNA Sequence That Restricts Parvovirus H-1 in Mouse Cells, Journal of Virology, vol.77, issue.6, pp.3851-3859, 2003.
DOI : 10.1128/JVI.77.6.3851-3858.2003

N. Giese, Z. Raykov, and L. Demartino, Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice, Cancer Gene Therapy, vol.9, issue.5, pp.432-474, 2002.
DOI : 10.1038/sj.cgt.7700457

T. Schaarschmidt, J. Merkord, and U. Adam, Expression of Multidrug Resistance Proteins in Rat and Human Chronic Pancreatitis, Pancreas, vol.28, issue.1, pp.45-52, 2004.
DOI : 10.1097/00006676-200401000-00007

D. Mutter, A. Hajri, and V. Tassetti, Increased tumor growth and spread after laparoscopy vs laparotomy, Surgical Endoscopy, vol.13, issue.4, pp.365-70, 1999.
DOI : 10.1007/s004649900991

J. Bennett, P. Adusumilli, and H. Petrowsky, Upregulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207), FASEB J, vol.18, pp.1001-1004, 2004.

Z. Raykov, G. Balboni, and M. Aprahamian, Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases, International Journal of Cancer, vol.5, issue.5, pp.742-751, 2004.
DOI : 10.1002/ijc.20013

X. Shi, S. Liu, and . Kleeffj, Acquired Resistance of Pancreatic Cancer Cells towards 5-Fluorouracil and Gemcitabine Is Associated with Altered Expression of Apoptosis-Regulating Genes, Oncology, vol.62, issue.4, pp.354-62, 2002.
DOI : 10.1159/000065068

H. Kasuya, Y. Nishiyama, and S. Nomoto, Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy, Cancer Gene Therapy, vol.148, issue.6, pp.533-575, 2007.
DOI : 10.1038/sj.cgt.7701049

S. Freytag, K. Barton, and S. Brown, Replication-competent Adenovirus-mediated Suicide Gene Therapy with Radiation in a Preclinical Model of Pancreatic Cancer, Molecular Therapy, vol.15, issue.9, pp.1600-1606, 2007.
DOI : 10.1038/sj.mt.6300212

C. Halloran, P. Ghaneh, and S. Shore, 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells, The Journal of Gene Medicine, vol.6, issue.5, pp.514-539, 2004.
DOI : 10.1002/jgm.540

R. Prestwich, K. Harrington, R. Vile, and A. Melcher, Immunotherapeutic potential of oncolytic virotherapy, The Lancet Oncology, vol.9, issue.7, pp.610-612, 2008.
DOI : 10.1016/S1470-2045(08)70163-3

Z. Raykov, S. Grekova, and A. Galabov, Combined oncolytic and vaccination activities of parvovirus H-1 in a metastatic tumor model, Oncology Reports, vol.17, pp.1493-1502, 2007.
DOI : 10.3892/or.17.6.1493

J. Plate, A. Plate, and S. Shott, Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas, Cancer Immunology, Immunotherapy, vol.45, issue.9, pp.915-940, 2005.
DOI : 10.1007/s00262-004-0638-1

A. Nowak, B. Robinson, and R. Lake, Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy, Cancer Res, vol.62, pp.2353-2361, 2002.